COVID-19

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers about the effect of coronavirus disease 2019 (COVID-19) on cancer clinical trials.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.

The level of protection for the single-dose COVID-19 vaccine was 72% in the United States compared to 57% in South Africa at 28 days post-vaccination, suggesting lower efficacy against the emerging South African variant.

All the states that passed laws require flu vaccines to be offered to hospital employees.

As experts seek to minimize hospitalizations during flu season and a pandemic, reformulated dapsone could offer a cost-effective solution.

In a progress update on COVID-19 vaccine administration and testing in Walgreens pharmacies, speakers discussed the rollout and implementation of the COVID-19 vaccination process in LTC facilities.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the COVID-19 vaccine.

In addition to stress and burnout caused by the COVID-19 pandemic, pharmacists face threats of physical violence and online doxxing.

Observational studies have suggested that vitamin D supplementation could lower the odds of developing respiratory infections, but randomized trials have had mixed results.

Additional randomized clinical trials are warranted to determine the mechanism between the 2 diseases.

Patients with HIV who were hospitalized with COVID-19 were found to have high proportions of HIV virologic control on antiretroviral therapy.

Sanofi has agreed to bottle and package at least 125 million doses of the COVID-19 vaccine BNT162b2 from Pfizer and BioNTech.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the role of independent pharmacies in the country during the COVID-19 pandemic.

Pfizer’s and Moderna’s receive Emergency Use Authorization in the United States from the FDA.

This year, pharmacists’ role will continue to evolve because of, or despite, the COVID-19 pandemic.

There has been a 25% increase in food insufficiency among Americans during the COVID-19 pandemic, according to a recent study.

In addition to communicating about COVID-19 vaccine eligibility, uses for online portals include requesting prescription refills, seeking advice on health concerns, and scheduling appointments.

The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.

Following the release of the Biden administration’s COVID-19 response strategy, NCPA issued its support and urged the government to also consider engaging independent pharmacies in its implementation.

Amantadine, a treatment that was originally used as an agent against influenza A, lost efficacy due to viral resistance.

Study finds that death was significantly less likely for type 2 diabetes subjects taking metformin, compared to those not taking metformin.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

During this study, no patient receiving TDF and FTC was admitted to intensive care or died.

Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.

NCCN states that all patients with active cancer, or with active, recent, or planned cancer treatment, should be considered highest priority to receive one of the COVID-19 vaccines granted emergency use authorization.